Recent work demonstrated that TROP2 behaved as a true oncogene leading to the tumorigenesis and invasiveness in colorectal cancer cell lines [8], and the overexpression of TROP2 was closely associated with cancer progression and poor prognosis. Here, TACSTD2 is linked to colorectal cancer.